Vincent H. Gattone

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

Vincent H. Gattone, Xiaofang Wang, Peter C. Harris et al. · Nature Medicine · 2003 · 665 citations

Molecular Pharmacology, Urology, Sodium Homeostasis +4

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

Vicente E. Torres, Xiaofang Wang, Qi Qian et al. · Nature Medicine · 2004 · 479 citations

Glomerulonephritis, Urology, Renal Disease +8

TGF-β1–Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis

Fernanda Teixeira Borges, Sónia A. Melo, Berna C. Özdemir et al. · Journal of the American Society of Nephrology · 2012 · 400 citations · Full text

Extracellular Microvesicles, Cell Proliferation, Cytoskeleton +24

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

Keizo Kanasaki, Kristin Palmsten, Hikaru Sugimoto et al. · Nature · 2008 · 377 citations

Eclampsia, Maternal Cardiovascular Outcome, Physiology +5

Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat

Xiaofang Wang, Vincent H. Gattone, Peter C. Harris et al. · Journal of the American Society of Nephrology · 2005 · 332 citations · Full text